Get Started

Artificial Intelligence Rivus Pharmaceuticals | Improving Cardio-metabolic Health

Enterprise, Biotechnology, Healthcare, Pharmaceutical, Metabolism, Cardiovascular Diseases Detecting Charlottesville, Virginia, United States

Artificial Intelligence

Rivus Pharmaceuticals | Improving Cardio-metabolic Health

Biotechnology, Healthcare, Pharmaceutical, Metabolism, Cardiovascular Diseases Detecting

Charlottesville, Virginia, United States

Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more

Total Funding: N/A

Funding Stage: N/A

Business Stage: Scaling Up

Market: B2B

Company Size: 1 to 25

Founded: 2019

Date

Round

$ Raised

Investors

07/20/2021

Series A

$35M

Longitude Capital, Medicxi Ventures

Date : 07/20/2021

Round: Series A

$ Raised: $35M

Investors: Longitude Capital, Medicxi Ventures

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Rivus Pharmaceuticals

Allen Cunningham
President and CEO

Mikael Herlevsen
Director, IP

Rivus Pharmaceuticals - Manage Profile

Rivus Pharmaceuticals is growing. Want to work at Rivus Pharmaceuticals? Rivus Pharmaceuticals is hiring. Join team at Rivus Pharmaceuticals

World's Most Promising AI/ML Startups